An investigation into the efficacy of modulated CBT for patients with acquired brain injury suffering from anger management difficulties. -A multi-center randomized controlled trial.

An investigation into the efficacy of modulated CBT for patients with acquired brain injury suffering from anger management difficulties. -A multi-center randomized controlled trial. - CBT-ABI project(RCT)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038085

Enrollment

Registered

2019-09-24

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acquired brain injury

Interventions

Weekly or biweekly individual CBT (cognitive behavior therapy) over 3 months (8 sessions

those with the attendance rate of more than 80% of 8 sessions can be included for the analysis) Weekly or biweekly individual talking control over 3 months (8 sessions

those with the attendance rate of more than 80% of 8 sessions can be included for the analysis)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Those with clinically severe distress or functional disorders in terms of social, occupational or other significant aspects due to the difficulty of anger control -Those with acquired brain injury more than half a year after the damageous event -Those judged as capable of carrying out the required test or psychological intervention on the designated day after the informed consent -Those with ability to both understand and agree with informed consent in Japanese

Exclusion criteria

Exclusion criteria: -Those under any treatment (or therapy is required) for substance-related disorders (except nicotine addiction) -Those with too severe psychiatric or neurological disorders to attend the research -Those with severe medical complication such as live dysfunction, renal dysfunction, endocrine disease -Those ineligible to MRI implementation due to implanted metal in the body, tattoos or other reasons -Those receiving any specific intensive psychotherapy including CBT elsewhere during the trial -Those judged as no therapeutic indication of CBT by the researchers -Strong suicidal ideation

Design outcomes

Primary

Measure	Time frame
STAXI-2	—

Countries

Japan

Contacts

Public ContactMirai So

Tokyo Dental College Department of Psychiatry, Ichikawa General Hospital

somirai@tdc.ac.jp047-322-0151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026